Patent · US Active

Method for preparing nicotinamide mononucleotide cocrystal

US11932602B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 6, 2022
Grant dateMar 19, 2024
Priority date
Expiry dateNov 12, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure provides a method for preparing a nicotinamide mononucleotide cocrystal, and aims to solve the technical problems of larger content/weight difference and inconsistent quality of nicotinamide mononucleotide (NMN) medicines or health care products due to poor fluidity of existing nicotinamide mononucleotide crystals. The method includes the steps of mixing nicotinamide mononucleotide as an active pharmaceutical ingredient with isonicotine as a cocrystal former by adopting solution synthesis and then performing crystal precipitation. The method has the advantages of simple operation and wide application range.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.